| 0 |
Bispecific CD20-directed CD3 T Cell Engager [EPC] |
1 |
0.0002 |
| 1 |
Antiseptic [EPC] |
1 |
0.0002 |
| 2 |
RANK Ligand Inhibitor [EPC] |
15 |
0.0001 |
| 3 |
BCL-2 Inhibitor [EPC] |
3 |
0.0000 |
| 4 |
Poly(ADP-Ribose) Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 5 |
Ester Local Anesthetic [EPC] |
2 |
0.0000 |
| 6 |
Androgen [EPC] |
1 |
0.0000 |
| 7 |
Aromatase Inhibitor [EPC] |
4 |
0.0000 |
| 8 |
Sympathomimetic-like Agent [EPC] |
1 |
0.0000 |
| 9 |
Dipeptidyl Peptidase 4 Inhibitor [EPC] |
1 |
0.0000 |
| 10 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
3 |
0.0000 |
| 11 |
Non-Standardized Chemical Allergen [EPC] |
2 |
0.0000 |
| 12 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
3 |
0.0000 |
| 13 |
Janus Kinase Inhibitor [EPC] |
4 |
0.0000 |
| 14 |
Estrogen Receptor Antagonist [EPC] |
1 |
0.0000 |
| 15 |
General Anesthetic [EPC] |
1 |
0.0000 |
| 16 |
Amide Local Anesthetic [EPC] |
2 |
0.0000 |
| 17 |
Epidermal Growth Factor Receptor Antagonist [EPC] |
1 |
0.0000 |
| 18 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
2 |
0.0000 |
| 19 |
Antiarrhythmic [EPC] |
2 |
0.0000 |
| 20 |
Antirheumatic Agent [EPC] |
2 |
0.0000 |
| 21 |
Erythropoiesis-stimulating Agent [EPC] |
1 |
0.0000 |
| 22 |
P2Y12 Platelet Inhibitor [EPC] |
2 |
0.0000 |
| 23 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
21 |
0.0000 |
| 24 |
Nitroimidazole Antimicrobial [EPC] |
1 |
0.0000 |
| 25 |
Topoisomerase Inhibitor [EPC] |
1 |
0.0000 |
| 26 |
Azole Antifungal [EPC] |
2 |
0.0000 |
| 27 |
CD20-directed Cytolytic Antibody [EPC] |
4 |
0.0000 |
| 28 |
Platelet Aggregation Inhibitor [EPC] |
7 |
0.0000 |
| 29 |
Xanthine Oxidase Inhibitor [EPC] |
2 |
0.0000 |
| 30 |
Nitrate Vasodilator [EPC] |
1 |
0.0000 |
| 31 |
Corticosteroid [EPC] |
14 |
0.0000 |
| 32 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
1 |
0.0000 |
| 33 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
1 |
0.0000 |
| 34 |
Dihydropyridine Calcium Channel Blocker [EPC] |
3 |
0.0000 |
| 35 |
Proteasome Inhibitor [EPC] |
1 |
0.0000 |
| 36 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 37 |
Phosphodiesterase 5 Inhibitor [EPC] |
1 |
0.0000 |
| 38 |
Serotonin-3 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 39 |
Nucleoside Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 40 |
Prostacycline Vasodilator [EPC] |
1 |
0.0000 |
| 41 |
Interleukin-6 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 42 |
Kinase Inhibitor [EPC] |
4 |
0.0000 |
| 43 |
Leukocyte Growth Factor [EPC] |
1 |
0.0000 |
| 44 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 45 |
Microtubule Inhibitor [EPC] |
1 |
0.0000 |
| 46 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
1 |
0.0000 |
| 47 |
HMG-CoA Reductase Inhibitor [EPC] |
2 |
0.0000 |
| 48 |
Proton Pump Inhibitor [EPC] |
3 |
0.0000 |
| 49 |
Endothelin Receptor Antagonist [EPC] |
1 |
0.0000 |
| 50 |
Expectorant [EPC] |
1 |
0.0000 |
| 51 |
Thiazide Diuretic [EPC] |
1 |
0.0000 |
| 52 |
Folate Analog Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 53 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 54 |
Loop Diuretic [EPC] |
2 |
0.0000 |
| 55 |
Alkylating Drug [EPC] |
1 |
0.0000 |
| 56 |
Thalidomide Analog [EPC] |
2 |
0.0000 |
| 57 |
Opioid Agonist [EPC] |
1 |
0.0000 |
| 58 |
Platinum-based Drug [EPC] |
1 |
0.0000 |
| 59 |
Vitamin D [EPC] |
1 |
0.0000 |
| 60 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 61 |
Vitamin B12 [EPC] |
1 |
0.0000 |
| 62 |
Vitamin C [EPC] |
1 |
0.0000 |
| 63 |
GLP-1 Receptor Agonist [EPC] |
1 |
0.0000 |
| 64 |
Tumor Necrosis Factor Blocker [EPC] |
1 |
0.0000 |